China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter Clinical Study of Recombinant Human Thrombopoietin (rhTPO) in the Treatment of Thrombocytopenia Complicated with Infection in Patients with Acute-on-Chronic Liver Failure (ACLF)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130254
Registration Time: 2026/08/18
Type: Interventional study
Primary Sponsor: Shandong Public Health Clinical Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338352
Published by HT Digital Content Services with permission from Health Daily Digest....